Search results for "Chronic renal disease"
showing 4 items of 4 documents
Calidad de la farmacoterapia y seguridad de los pacientes en hemodiálisis tratados con estimulantes eritropoyéticos
2008
Objective: To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesis-stimulating agents. Method: Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesis- stimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dl) and those with values above the safety limit (≥ 12.5g/dl) were compared every four months and the average percentage of time with haemoglobin values within the ta…
La qualità della vita in soggetti in età evolutiva affetti da patologie renali croniche
2005
Atra. Renai pathologies bave an hard impact on ili children's life style, psychic and physical development. Inthelastyears, evenif medicai cures allowed these children to live longer and to bave a better quality of life, today both their families and themselves bave to face a lot of difficulties due to thè kind of pathology. These cbildren show behaviour troubles, bad sociability, aggressiveness, poorschool performance, anxiety and depression, and then thè subjects with chronic renai failure show a retard in neurological and cognitive development In this study we evatuated thè impact that thè chronic renai illness has on children and adolescente' quality life. Methods. Por this study, we ba…
Pharmacotherapy quality and patient safety in haemodialysis patients treated with erythropoiesis-stimulating agents
2008
Abstract Objective To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesisstimulating agents. Method Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesisstimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dL) and those with values above the safety limit (≥12.5 g/dL) were compared every 4 months and the average percentage of time with haemoglobin values within the t…
The Mediterranean diet could be an exceptional support for patients with chronic renal disease
2020
Chronic renal disease (CKD) is a social problem affecting millions of patients characterized by loss of renal function and related to metabolic diseases. The approach from the dietary point of view to this problem could be a perfect strategy to slow down the progression of the disease and at the same time the problems of malnutrition typical of CKD. Several studies show that the Mediterranean diet (MD) may play a key role in the control of the early stages of the disease. Even if the MD showed to be the best diet for the control of metabolic diseases and for the general well-being, in the case of the patient with CKD, should be adapted in what is called the DASH diet, characterized by the t…